Literature DB >> 17094102

Independent validation of SCOPA-psychosocial and metric properties of the PDQ-39 Brazilian version.

Francisco Javier Carod-Artal1, Pablo Martinez-Martin, Antonio Pedro Vargas.   

Abstract

The objective of this study was to perform an independent validation of the Scales for Outcomes in Parkinson's Disease-Psychosocial questionnaire (SCOPA-PS) and assessment of the Parkinson's Disease Questionnaire (PDQ-39), Brazilian version. Patients were evaluated by means of the Unified Parkinson's Disease Rating Scale, Hoehn and Yahr staging (HY), Schwab and England scale, Mini-Mental State Examination, and Hospital Anxiety and Depression Scale. Health-related quality of life was evaluated using the MOS-Short Form 36 (SF-36), PDQ-39, and SCOPA-PS. One hundred forty-four patients were included (mean age, 62 years; 53.5% males; mean duration of illness, 6.6 years; HY, 1-4). Mean SCOPA-PS and PDQ-39 Summary Index (SI) were 39.2 and 40.7, respectively. The internal consistency of SCOPA-PS (Cronbach's alpha = 0.84; item-total correlation, 0.44-0.73) and PDQ-39 dimensions (alpha = 0.61-0.85; item-total correlation, 0.46-0.82) were satisfactory. Concerning the stability of the questionnaires, intraclass correlation coefficient (ICC) values were 0.71 for the SCOPA-PS and 0.86 for the PDQ-39 SI. ICC for PDQ-39 dimensions ranged from 0.52 (social support) to 0.80 (stigma). Standard error of measurement (SEM) values for each PDQ-39 dimension ranged from 0.49 (emotional well-being) to 17.52 (social support). SEM values for SCOPA-PS and PDQ-39 SI were 11.84 and 6.72, respectively. A significant correlation of SCOPA-PS and PDQ-39 SI with the SF-36 physical (-0.42 and -0.52, respectively) and mental components (-0.41) was found. Correlation between SCOPA-PS and PDQ-39 SI was 0.73 (all coefficients, P < 0.0001). The SCOPA-PS and PDQ-39, Brazilian versions, have satisfactory metric attributes. Copyright 2006 Movement Disorder Society.

Entities:  

Mesh:

Year:  2007        PMID: 17094102     DOI: 10.1002/mds.21216

Source DB:  PubMed          Journal:  Mov Disord        ISSN: 0885-3185            Impact factor:   10.338


  13 in total

1.  Health-related quality of life of australians with Parkinson disease: a comparison with international studies.

Authors:  Sze-Ee Soh; Jennifer L McGinley; Jennifer J Watts; Robert Iansek; Meg E Morris
Journal:  Physiother Can       Date:  2012       Impact factor: 1.037

2.  Reliability and validity of PDQ-39: a quality-of-life measure for patients with PD in China.

Authors:  Jing-Lin Zhang; Piu Chan
Journal:  Qual Life Res       Date:  2011-10-09       Impact factor: 4.147

3.  Quality of life in Parkinson's disease: Italian validation of the Parkinson's Disease Questionnaire (PDQ-39-IT).

Authors:  Giovanni Galeoto; Francesca Colalelli; Perla Massai; Anna Berardi; Marco Tofani; Mariangela Pierantozzi; Annamaria Servadio; Andrea Fabbrini; Giovanni Fabbrini
Journal:  Neurol Sci       Date:  2018-08-07       Impact factor: 3.307

Review 4.  Effects of physical exercise programs on cognitive function in Parkinson's disease patients: A systematic review of randomized controlled trials of the last 10 years.

Authors:  Franciele Cascaes da Silva; Rodrigo da Rosa Iop; Laiana Cândido de Oliveira; Alice Mathea Boll; José Gustavo Souza de Alvarenga; Paulo José Barbosa Gutierres Filho; Lídia Mara Aguiar Bezerra de Melo; André Junqueira Xavier; Rudney da Silva
Journal:  PLoS One       Date:  2018-02-27       Impact factor: 3.240

5.  Effects of virtual rehabilitation versus conventional physical therapy on postural control, gait, and cognition of patients with Parkinson's disease: study protocol for a randomized controlled feasibility trial.

Authors:  Keyte Guedes Silva; Tatiana Beline De Freitas; Flávia Doná; Fernando Freitas Ganança; Henrique Ballalai Ferraz; Camila Torriani-Pasin; José Eduardo Pompeu
Journal:  Pilot Feasibility Stud       Date:  2017-12-06

6.  Translation and validation of the korean version of the 39-item Parkinson's disease questionnaire.

Authors:  Do-Young Kwon; Jae Woo Kim; Hyeo-Il Ma; Tae-Beom Ahn; Jinwhan Cho; Phil Hyu Lee; Sun Ju Chung; Joong-Seok Kim; Jong Sam Baik; Seong-Beom Koh
Journal:  J Clin Neurol       Date:  2013-01-03       Impact factor: 3.077

7.  Cross-cultural validity, reliability, and psychometric properties of the persian version of the scales for outcomes in Parkinson's disease-psychosocial questionnaire.

Authors:  Seyed-Mohammad Fereshtehnejad; Farzaneh Farhadi; Hasti Hadizadeh; Gholam Ali Shahidi; Ahmad Delbari; Johan Lökk
Journal:  Neurol Res Int       Date:  2014-04-07

8.  Parkinson's disease: Impact of clinical and cognitive aspects on quality of life.

Authors:  Glória Maria Almeida Souza Tedrus; Lineu Correa Fonseca; Patrícia Mencaroni Kange
Journal:  Dement Neuropsychol       Date:  2010 Apr-Jun

9.  Neuropsychological and quality of life assessment in patients with Parkinson's disease submitted to bilateral deep brain stimulation in the subthalamic nucleus.

Authors:  Alessandra Shenandoa Heluani; Fábio Henrique de Gobbi Porto; Sergio Listik; Alexandre Walter de Campos; Alexandre Aluizio Costa Machado; Arthur Cukiert; José Oswaldo de Oliveira
Journal:  Dement Neuropsychol       Date:  2012 Oct-Dec

10.  The impact of cognitive performance on quality of life in individuals with Parkinson's disease.

Authors:  Maira Rozenfeld Olchik; Annelise Ayres; Marcieli Ghisi; Artur Francisco Schumacher Schuh; Carlos Roberto Mello Rieder
Journal:  Dement Neuropsychol       Date:  2016 Oct-Dec
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.